The origin of blood and lymphatic vessels in high-grade serous adenocarcinoma of ovary (HGSOC) is uncertain. We evaluated the potential of cancer stem cells (CSCs) in HGSOC to contribute to their formation. Using spheroids as an in vitro model for CSCs, we have evaluated their role in primary malignant cells (PMCs) in ascites from previously untreated patients with HGSOC and cell lines. Spheroids from PMCs grown under specific conditions showed significantly higher expression of endothelial, pericyte and lymphatic endothelial markers. These endothelial and lymphatic cells formed tube-like structures, showed uptake of Dil-ac-LDL and expressed endothelial nitric oxide synthase confirming their endothelial phenotype. Electron microscopy demonstrated classical Weibel–Palade bodies in differentiated cells. Genetically, CSCs and the differentiated cells had a similar identity. Lineage tracking using green fluorescent protein transfected cancer cells in nude mice confirmed that spheroids grown in stem cell conditions can give rise to all three cells. Bevacizumab, a monoclonal antibody that targets vascular endothelial growth factor inhibited the differentiation of spheroids to endothelial cells in vitro. These results suggest that CSCs contribute to angiogenesis and lymphangiogenesis in serous adenocarcinoma of the ovary, which can be inhibited.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Hillen F, Griffioen AW (2007) Tumour vascularization: sprouting angiogenesis and beyond. Cancer Metastasis Rev 26:489–502
Krishna Priya S, Nagare RP, Sneha VS et al (2016) Tumour angiogenesis: origin of blood vessels. Int J Cancer 139:729–735
Visvader JE, Lindeman GJ (2012) Cancer stem cells: current status and evolving complexities. Cell Stem Cell 10:717–728
Ricci-Vitiani L, Pallini R, Biffoni M et al (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468:824–828
Wang R, Chadalavada K, Wilshire J et al (2010) Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468:829–833
Cheng L, Huang Z, Zhou W et al (2013) Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cell 153:139–152
Bussolati B, Grange C, Sapino A, Camussi G (2009) Endothelial cell differentiation of human breast tumour stem/progenitor cells. J Cell Mol Med 13:309–319
Lai C-Y, Schwartz BE, Hsu M-Y (2012) CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry. Cancer Res 72:5111–5118
Sundar SS, Ganesan TS (2007) Role of lymphangiogenesis in cancer. J Clin Oncol 25:4298–4307
Nagare RP, Sneha S, Priya SK, Ganesan TS (2017) Cancer stem cells—are surface markers alone sufficient? Curr Stem Cell Res Ther 12:37–44
Matsuda K, Ohga N, Hida Y et al (2010) Isolated tumor endothelial cells maintain specific character during long-term culture. Biochem Biophys Res Commun 394:947–954
Voyta JC, Via DP, Butterfield CE, Zetter BR (1984) Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol 99:2034–2040
Lamas S, Marsden PA, Li GK et al (1992) Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 89:6348–6352
DeCicco-Skinner KL, Henry GH, Cataisson C et al (2014) Endothelial cell tube formation assay for the in vitro study of angiogenesis. J Vis Exp JoVE 91:e51312
Weibel ER, Palade GE (1964) New cytoplasmic components in arterial endothelia. J Cell Biol 23:101–112
Jaffe EA, Nachman RL, Becker CG, Minick CR (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2745–2756
Valentijn KM, Sadler JE, Valentijn JA et al (2011) Functional architecture of Weibel–Palade bodies. Blood 117:5033–5043
Hirschberg RM, Sachtleben M, Plendl J (2005) Electron microscopy of cultured angiogenic endothelial cells. Microsc Res Technol 67:248–259
Au-Yeung G, Lang F, Azar WJ et al (2017) Selective targeting of cyclin E1-amplified high-grade serous ovarian cancer by cyclin-dependent kinase 2 and AKT inhibition. Clin Cancer Res 23:1862–1874
Gao J, Aksoy BA, Dogrusoz U et al (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6:1
Kaipainen A, Korhonen J, Mustonen T et al (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92:3566–3570
Shibuya M, Claesson-Welsh L (2006) Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 312:549–560
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Krishna Priya S, Kumar K, Hiran KR et al (2017) Expression of a novel endothelial marker, C-type lectin 14A, in epithelial ovarian cancer and its prognostic significance. Int J Clin Oncol 22:107–117
Hall M, Gourley C, McNeish I et al (2013) Targeted anti-vascular therapies for ovarian cancer: current evidence. Br J Cancer 108:250–258
Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473:298–307
Liao J, Qian F, Tchabo N et al (2014) Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism. PLoS ONE 9:e84941
Condello S, Morgan CA, Nagdas S et al (2015) β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids. Oncogene 34:2297–2308
Alvero AB, Fu H-H, Holmberg J et al (2009) Stem-like ovarian cancer cells can serve as tumor vascular progenitors. Stem Cells 27:2405–2413
Dictor M, Mebrahtu S, Selg M et al (2007) Lymphatic origin from embryonic stem cells. Cancer Treat Res 135:25–37
Zhou X-M, Wang D, He H-L et al (2017) Bone marrow derived mesenchymal stem cells involve in the lymphangiogenesis of lung cancer and Jinfukang inhibits the involvement in vivo. J Cancer 8:1786–1794
Chen S-H, Murphy DA, Lassoued W et al (2008) Activated STAT3 is a mediator and biomarker of VEGF endothelial activation. Cancer Biol Ther 7:1994–2003
Jiang B-H, Liu L-Z (2009) PI3K/PTEN signaling in angiogenesis and tumorigenesis. Adv Cancer Res 102:19–65
Simons M, Gordon E, Claesson-Welsh L (2016) Mechanisms and regulation of endothelial VEGF receptor signalling. Nat Rev Mol Cell Biol 17:611–625
Tang S, Xiang T, Huang S et al (2016) Ovarian cancer stem-like cells differentiate into endothelial cells and participate in tumor angiogenesis through autocrine CCL5 signaling. Cancer Lett 376:137–147
Sood AK, Seftor EA, Fletcher MS et al (2001) Molecular determinants of ovarian cancer plasticity. Am J Pathol 158:1279–1288
Perren TJ, Swart AM, Pfisterer J et al (2011) A phase 3 trial of bevacizumab in ovarian cancer. N Engl J Med 365:2484–2496
Stark D, Nankivell M, Pujade-Lauraine E et al (2013) Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial. Lancet Oncol 14:236–243
Burger RA, Brady MF, Bookman MA et al (2011) Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Engl J Med 365:2473–2483
Yi S, Zeng L, Kuang Y et al (2017) Antiangiogenic drugs used with chemotherapy for patients with recurrent ovarian cancer: a meta-analysis. OncoTargets Ther 10:973–984
Agliano A, Calvo A, Box C (2017) The challenge of targeting cancer stem cells to halt metastasis. Semin Cancer Biol 44:25–42
Marquardt S, Solanki M, Spitschak A et al (2018) Emerging functional markers for cancer stem cell-based therapies: understanding signaling networks for targeting metastasis. Semin Cancer Biol 53:90–109
Batlle E, Clevers H (2017) Cancer stem cells revisited. Nat Med 23:1124–1134
Kaipparettu BA, Kuiatse I, Tak-Yee Chan B et al (2008) Novel egg white-based 3-D cell culture system. Biotechniques 45(165–168):170–171
Kubota Y, Kleinman HK, Martin GR, Lawley TJ (1988) Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol 107:1589–1598
Mousseau Y, Mollard S, Qiu H et al (2014) In vitro 3D angiogenesis assay in egg white matrix: comparison to Matrigel, compatibility to various species, and suitability for drug testing. Lab Invest 94:340–349
We thank Department of Biotechnology (DBT), Government of India for funding this project and Indian Council for Medical Research (ICMR) for the Senior Research Fellowship for S.K.P, B.S and R.P.N. We also thank Department of Science and Technology and University Grants Commission for the Research Fellowships to M.P and S.S, respectively. We thank Dr.V.Sridevi and Dr.Ujwala, Cancer Institute for their help in identifying patients with ovarian cancer. We are grateful to the Staff and nurses of Department of Medical Oncology, flow cytometry facility at the Department of Molecular Oncology, Cancer Institute and IIT Madras, Departments of Electron microscopy, Pathology, Epidemiology and Statistics at Cancer Institute for their help. We also thank Dr.Manoj Garg for his suggestions and help for the in vivo experiments.
Funding were provided by Department of Biotechnology, Ministry of Science and Technology (Grant No. 102/IFD/SAN/890/2016-2017), Indian Council of Medical Research (Grant No. 3/2/2/169/2012-NCD III) and Department of Science and Technology, Ministry of Science and Technology (Grant No. IF40020).
Conflict of interest
The authors declare no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Krishnapriya, S., Sidhanth, C., Manasa, P. et al. Cancer stem cells contribute to angiogenesis and lymphangiogenesis in serous adenocarcinoma of the ovary. Angiogenesis 22, 441–455 (2019). https://doi.org/10.1007/s10456-019-09669-x
- Cancer stem cells
- Endothelial cells
- Serous adenocarcinoma of ovary